Peer-reviewedCC BY-NCClinical pharmacology and therapeutics
Overview of Regulatory Guidelines Related to Methods and Models for Small Populations
- 1IQ Health, Radboud University Medical Center
- 2Inserm, Université Paris Cité, Inria, HeKA
- 3Swedish Medical Products Agency
Related
- Non-interventional and medical management of lower urinary tract symptoms related to benign prostatic hyperplasia in men: Guidelines of the French LUTS Committee (CTMH)
- RegDesign-Bench: Benchmarking computational methods for cell-type-specific regulatory DNA design
- Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2-related disorders
- The CRISPR–Cas system functions a regulatory module in diverse cellular processes in Salmonella enterica serovar Typhi and related Enterobacteriaceae
- Regulatory function and effective variation identification of egg-laying related candidate gene ANK2 in chickens
BibTeX
@article{sluijterman2026overview,
title = {{Overview of Regulatory Guidelines Related to Methods and Models for Small Populations}},
author = {Laurens Sluijterman and Letao Li and Kristin E. Karlsson and Vincent Damotte and Sarah Zohar and Kit Roes and Joanna IntHout},
journal = {Clinical pharmacology and therapeutics},
year = {2026},
month = oct,
doi = {10.1002/cpt.70523},
url = {https://europepmc.org/article/PMC/PMC13660450},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Overview of Regulatory Guidelines Related to Methods and Models for Small Populations
AU - Laurens Sluijterman
AU - Letao Li
AU - Kristin E. Karlsson
AU - Vincent Damotte
AU - Sarah Zohar
AU - Kit Roes
AU - Joanna IntHout
PY - 2026
DA - 2026/10/13
JO - Clinical pharmacology and therapeutics
DO - 10.1002/cpt.70523
UR - https://europepmc.org/article/PMC/PMC13660450
SN - 0009-9236
SN - 1532-6535
ER -